December 07, 2016 10:00 PM ET

Life Sciences Tools and Services

Company Overview of FlowMetric, Inc.

Company Overview

FlowMetric, Inc., a contract resource organization, provides polychromatic flow cytometry and immunohistochemistry services to biopharmaceutical and drug discovery companies. It offers flow cytometry services, including intracellular cytokines, cell surface markers/biomarkers, cell signaling proteins, phosphoproteins, cellular-antibody binding and multiplexed bead assays, screening and optimization of drug candidates, potency assays, pharmacokinetics, neutralizing antibodies, and antigen-specific T cell multimer analysis. The company also provides flow cytometry analysis that supports pre-clinical drug development, including immunophenotyping, peripheral blood cross-reactivity, binding activ...

3805 Old Easton Road

Pennsylvania Biotechnology Center of Bucks County

Doylestown, PA 18902

United States

Founded in 2010





Key Executives for FlowMetric, Inc.

Founder, Chairman and Chief Executive Officer
President and Director of Human Resources
Age: 56
Director of Business Development
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

FlowMetric, Inc. Key Developments

FlowMetric, Inc. Appoints Floyd E. Fox as Chief Scientific Officer

FlowMetric, Inc. announced that they have appointed Floyd E. Fox, Ph.D. as Chief Scientific Officer. Dr. Fox will be responsible for leading FlowMetric’s research and development strategy and assuring all client support activities are carried out according the scientific and regulatory standards. Dr. Fox, an Immunologist by training, is an expert in the conception, development and implementation of innovative non-clinical and clinical bioanalytical methods aimed at understanding the mechanism of action of biotherapeutics. Dr. Fox has nearly 25 years’ experience in the areas of non-clinical and clinical pharmacology, immunogenicity, cytokine biology, infection and inflammation, oncology and immunology. Prior to joining FlowMetric, Dr. Fox served for nearly 15 years at Eli Lilly and Company (Imclone Systems) in roles of increasing responsibility as Director and Senior Director, culminating and Associate Vice-President, Clinical Pharmacology and Drug Disposition. Dr. Fox was instrumental in the US and global marketing approval of Erbitux and Cyramza.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact FlowMetric, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at